Mizuho Securities analyst Ann Hynes has maintained their bullish stance on CVS stock, giving a Buy rating today. Ann Hynes has given her Buy ...

NEW YORK (Reuters) - As CVS Health's new CEO David Joyner steps into the top job after Karen Lynch's quick departure on ...

Walgreens also has over $20 billion of long-term leases, primarily stores. Although these don’t have to be funded in the same way as borrowings in a buyout, they are another call on its cashflow. At ...

Barclays analyst Andrew Mok CFA maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $82.00. The ...

That experience was in the back of my mind when reading about the struggles at CVS Health, which owns Aetna, and the ouster ...

The hits keep coming for CVS Health, which on Friday revealed new leadership and a bleaker-than-expected balance sheet.

Elevance (ELV) and CVS Health (CVS) led to a selloff among managed care companies this week after lower than expected ...

A trifecta of problems, some that started before she took the top job, ended the reign of one of the most powerful women in ...

During her time at the helm of CVS Health, former chief executive Karen Lynch often placed her complicated family history at ...

Shares of the health care conglomerate dropped after the sudden departure of Karen Lynch and a downbeat update on the state ...

CVS has been struggling with rising medical costs in its Medicare Advantage plans and slumping drugstore sales.

CVS Health CEO Karen Lynch has stepped down, with company shares sinking 19% this year. CVS Health also warned of disappointing third-quarter earnings.